Agios Pharmaceuticals (AGIO)
(Delayed Data from NSDQ)
$31.81 USD
+1.96 (6.55%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $31.80 -0.01 (-0.03%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/2/24 |
---|---|
Current Quarter | -1.63 |
EPS Last Quarter | -1.72 |
Last EPS Surprise | -4.88% |
ABR | 1.78 |
Earnings ESP
|
1.23% |
---|---|
Current Year | -5.28 |
Next Year | -5.87 |
EPS (TTM) | -6.34 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.99M | 9.88M | 82.01M | 94.83M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 12.92M | 14.91M | 234.18M | 160.76M |
Low Estimate | 7.10M | 7.50M | 30.50M | 65.40M |
Year ago Sales | 5.61M | 6.71M | 26.82M | 82.01M |
Year over Year Growth Est. | 60.18% | 47.27% | 205.75% | 15.63% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.63 | -1.63 | -5.28 | -5.87 |
# of Estimates | 7 | 5 | 8 | 7 |
Most Recent Consensus | -1.78 | -1.82 | -7.01 | -6.66 |
High Estimate | -1.48 | -1.46 | -2.82 | -4.34 |
Low Estimate | -1.78 | -1.82 | -7.13 | -7.11 |
Year ago EPS | -1.47 | -1.51 | -6.33 | -5.28 |
Year over Year Growth Est. | -10.88% | -7.95% | 16.59% | -11.22% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.63 | -1.63 | -5.28 | -5.87 |
7 Days Ago | -1.63 | -1.63 | -5.28 | -5.87 |
30 Days Ago | -1.63 | -1.63 | -5.28 | -5.88 |
60 Days Ago | -1.62 | -1.61 | -5.23 | -5.80 |
90 Days Ago | -1.53 | -1.54 | -4.74 | -5.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.61 | -1.63 | -6.47 | -6.31 |
Zacks Consensus Estimate | -1.63 | -1.63 | -5.28 | -5.87 |
Earnings ESP | 1.23% | 0.00% | -22.57% | -7.47% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.72 | -1.64 | -1.51 | -1.47 | NA |
Estimate | -1.64 | -1.69 | -1.60 | -1.72 | NA |
Difference | -0.08 | 0.05 | 0.09 | 0.25 | 0.08 |
Surprise | -4.88% | 2.96% | 5.63% | 14.53% | 4.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more